Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05df9bb5afc09dcaa19f4102006bc58b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a7ebd2ce5ef7e691bd44c48a88a2bfc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
filingDate |
2017-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c708bbf5cbaecb2625cc6c0959a60a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c05b1863c20430cceeeba53718efb575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8bcef1ebc5df93209e3994603e4ef93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10c94b3ee67b58a16ddd31c86c514ce4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21e3de5cf183092ea05e439cfa77e253 |
publicationDate |
2017-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017156461-A2 |
titleOfInvention |
Antigen-binding fusion proteins with modified hsp70 domains |
abstract |
The invention relates to fusion proteins comprising an antigen binding domain fused with a modified heat shock 70 protein. The invention further relates to methods of using the fusion proteins to induce an immune response to antigens and to treat diseases associated with antigens. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3509609-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364264-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11547694-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11325951-B2 |
priorityDate |
2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |